Home › Steatotic Liver Disease › Texas › The Woodlands
Steatotic Liver Disease clinical trials in The Woodlands, TX
4 studies for Steatotic Liver Disease are looking for participants at sites in and around The Woodlands (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Tomball · 9 mi away
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RecruitingPhase 3
- Akero Clinical Study Site, Kingwood · 20 mi away
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RecruitingPhase 3
- GSK Investigational Site, Tomball · 9 mi away
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RecruitingPhase 3
- GSK Investigational Site, Tomball · 9 mi away
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- New York City, NY16 studies
- Miami, FL16 studies
- San Diego, CA14 studies
- Austin, TX13 studies
- Houston, TX13 studies
- Richmond, VA12 studies
- Chandler, AZ10 studies
- Tucson, AZ10 studies
- Hialeah, FL9 studies
- Dallas, TX9 studies
- St. Louis, MO9 studies
Other studies in The Woodlands
- Non-Small Cell Lung Cancer15 studies
- Obesity12 studies
- Overweight10 studies
- Breast Cancer10 studies
- Macular Degeneration9 studies
- Cardiovascular Disease9 studies
- Metastatic Cancer9 studies
- Type 2 Diabetes7 studies
- Heart Failure7 studies
- Lung Cancer7 studies
- Atherosclerosis6 studies
- Geographic Atrophy6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.